CRP is one of the oldest clinical biomarkers used widely in routine clinical practice worldwide [[5], [6], [7], [8], [9]], and its use increased during the COVID-19 pandemic as a marker of disease severity and prognosis [6,7]. The gene discussed is CRP; the disease is COVID-19.